Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sodium Channel Mutations (SCN9A, SCN10A) in the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)

NCT05877274 is registered in ClinicalTrials.gov with Maxima Medical Center as lead sponsor.

NCT NCT05877274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05877274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sodium Channel Mutations (SCN9A, SCN10A) in the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)
Lead sponsor
Maxima Medical Center
Phase
Observational
Overall status
Unknown status
Start date
October 3, 2023
Completion date
December 31, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior cutaneous nerve entrapment syndrome, chronic pain syndrome, nerve entrapment syndrome